Receptor for advanced glycation endproducts mediates neutrophil migration across intestinal epithelium

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2483-2490

  Zen, Ke ^a   Chen, Celia X J ^a   Chen, Yi Tien ^a   Wilton, Rosemarie ^b   Liu, Yuan ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b ARGONNE NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BETA2 INTEGRIN; CD11B ANTIGEN; CD18 ANTIGEN; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL ADHESION; CELL JUNCTION; CONTROLLED STUDY; ENTERITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INTESTINE EPITHELIUM; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

EID: 33846924545     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2483     Document Type: Article

References (65)

1. Zen, K., Y. Liu, D. Cairo, and C. A. Parkos. 2002. CD11b/CD18-dependent interactions of neutrophils with intestinal epithelium are mediated by fucosylated proteoglycans. J. Immunol. 169: 5270-5278.
2. Diamond, M. S., R. Alon, C. A. Parkos, M. T. Quinn, and T. A. Springer. 1995. Heparin is an adhesive ligand for the leukocyte integrin Mac-1 (CD11b/CD1). J. Cell Biol. 130: 1473-1482.
3. Colgan, S. P., C. A. Parkos, D. McGuirk, H. R. Brady, A. A. Papayianni, G. Frendl, and J. L. Madara. 1995, Receptors involved in carbohydrate binding modulate intestinal epithelial-neutrophil interactions. J. Biol. Chem. 270: 10531-10539.
4. Lawrence, D. W., W. J. Bruyninckx, N. A. Louis, D. M. Lublin, G. L. Stahl, C. A. Parkos, and S. P. Colgan. 2003. Antiadhesive role of apical decay-accelerating factor (CD55) in human neutrophil transmigration across mucosal epithelia. J. Exp. Med. 198: 999-1010.
5. Bierhaus, A., T. Illmer, M. Kasper, T. Luther, P. Quehenberger, H. Tritschler, P. Wahl, R. Ziegler, M. Muller, and P. P. Nawroth. 1997. Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96: 2262-2271.
6. Liu, Y., S. K. Shaw, S. Ma, L. Yang, F. W. Luscinskas, and C. A. Parkos. 2004. Regulation of leukocyte transmigration: cell surface interactions and signaling events. J. Immunol. 172: 7-13.
7. Parkos, C. A., C. Delp, M. A. Arnaout, and J. L. Madara. 1991. Neutrophil migration across a cultured intestinal epithelium: dependence on a CD11b/CD18-mediated event and enhanced efficiency in physiological direction. J. Clin. Invest. 88: 1605-1612.
8. Zen, K., and C. A. Parkos. 2003. Leukocyte-epithelial interactions. Curr. Opin. Cell Biol. 15: 557-564.
9. Liu, Y., D. Merlin, S. L. Burst, M. Pochet, J. L. Madara, and C. A. Parkos. 2001. The role of CD47 in neutrophil transmigration: increased rate of migration correlates with increased cell surface expression of CD47. J. Biol. Chem. 276: 40156-40166.
10. Parkos, C. A. 1997. Molecular events in neutrophil transepithelial migration. BioEssays 19: 865-873.
11. Parkos, C. A., S. P. Colgan, M. S. Diamond, A. Nusrat, T. W. Liang, T. A. Springer, and J. L. Madara. 1996. Expression and polarization of intercellular adhesion molecule-1 on human intestinal epithelia: consequences for CD11b/CD18-mediated interactions with neutrophils. Mol. Med. 2: 489-505.
12. Zen, K., B. A. Babbin, Y. Liu, J. B. Whelan, A. Nusrat, and C. A. Parkos. 2004. JAM-C is a component of desmosomes and a ligand for CD11b/CD18-mediated neutrophil transepithelial migration. Mol. Biol. Cell 15: 3926-3937.
13. Santoso, S., U. J. Sachs, H. Kroll, M. Linder, A. Ruf, K. T. Preissner, and T. Chavakis. 2002. The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1. J. Exp. Med. 196: 679-691.
14. Chavakis, T., T. Keiper, R. Matz-Westphal, K. Hersemeyer, U. J. Sachs, P. P. Nawroth, K. T. Preissner, and S. Santoso. 2004. The junctional adhesion molecule-C promotes neutrophil transendothelial migration in vitro and in vivo. J. Biol. Chem. 279: 55602-55608.
15. Keiper, T., N. Al-Fakhri, E. Chavakis, A. N. Athanasopoulos, B. Isermann, S. Herzog, R. Saffrich, K. Hersemeyer, R. M. Bohle, J. Haendeler, et al. 2005. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J. 19: 2078-2080.
16. Chavakis, T., A. Bierhaus, N. Al-Fakhri, D. Schneider, S. Witte, T. Linn, M. Nagashima, J. Morser, B. Arnold, K. T. Preissner, and P. P. Nawroth. 2003. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198: 1507-1515.
17. Schmidt, A. M., M. Vianna, M. Gerlach, J. Brett, J. Ryan, J. Kao, C. Esposito, H. Hegarty, W. Hurley, M. Clauss, et al. 1992. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. Biol. Chem. 267: 14987-14997.
18. Schmidt, A. M., S. D. Yan, J. Brett, R. Mora, R. Nowygrod, and D. Stern. 1993. Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycatjon end products. J. Clin. Invest. 91: 2155-2168.
19. Schmidt, A. M., O. Hori, R. Cao, S. D. Yan, J. Brett, J. L. Wautier, S. Ogawa, K. Kuwabara, M. Matsumoto, and D. Stern. 1996. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 45(Suppl. 3): S77-S80.
20. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382: 685-691.
21. Hofmann, M. A., S. Drury, C. Fu, W. Qu, A. Taguchi, Y. Lu, C. Avila, N. Kambham, A. Bierhaus, P. Nawroth, et al. 1999. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97: 889-901.
22. Taguchi, A., D. C. Blood, G. del Toro, A. Canet, D. C. Lee, W. Qu, N. Tanji, Y. Lu, E. Lalla, C. Fu, et al. 2000. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405: 354-360.
23. Schmidt, A. M., S. D. Yan, S. F. Yan, and D. M. Stern. 2001. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108: 949-955.
24. Tanaka, N., H. Yonekura, S. Yamagishi, H. Fujimori, Y. Yamamoto, and H. Yamamoto. 2000. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-α through nuclear factor-κB, and by 17β-estradiol through Sp-1 in human vascular endothelial cells. J. Biol. Chem. 275: 25781-25790.
25. Li, J., and A. M. Schmidt. 1997. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J. Biol. Chem. 272: 16498-16506.
26. Wautier, J. L., C. Zoukourian, O. Chappey, M. P. Wautier, P. J. Guillausseau, R. Cao, O. Hori, D. Stern, and A. M. Schmidt. 1996. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats. J. Clin. Invest. 97: 238-243.
27. Schmidt, A. M., O. Hori, J. X. Chen, J. F. Li, J. Crandall, J. Zhang, R. Cao, S. D. Yan, J. Brett, and D. Stern. 1995. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96: 1395-1403.
28. Chavakis, T., A. Bierhaus, and P. P. Nawroth. 2004. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect. 6: 1219-1225.
29. Foell, D., T. Kucharzik, M. Kraft, T. Vogl, C. Sorg, W. Domschke, and J. Roth. 2003. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 52: 847-853.
30. Diamond, M. S., J. Garcia-Aguilar, J. K. Bickford, A. L. Corbi, and T. A. Springer. 1993. The I domain is a major recognition site on the leukocyte integrin Mac-1 (CD11b/CD18) for four distinct adhesion ligands. J. Cell Biol. 120: 1031-1043.
31. Zen, K., M. Utech, Y. Liu, I. Soto, A. Nusrat, and C. A. Parkos. 2004. Association of BAP31 with CD11b/CD18: potential role in intracellular trafficking of CD11b/CD18 in neutrophils. J. Biol. Chem. 279: 44924-44930.
32. Liu, Y., H. J. Buhring, K. Zen, S. L. Burst, F. J. Schnell, I. R. Williams, and C. A. Parkos. 2002. Signal regulatory protein (SIRPα), a cellular ligand for CD47, regulates neutrophil transmigration. J. Biol. Chem. 277: 10028-10036.
33. Wilton, R., M. A. Yousef, P. Saxena, M. Szpunar, and F. J. Stevens. 2006. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli. Protein Expr. Purif. 47: 25-35.
34. Reaves, T. A., S. P. Colgan, P. Selvaraj, M. M. Pochet, S. Walsh, A. Nusrat, T. W. Liang, J. L. Madara, and C. A. Parkos. 2001. Neutrophil transepithelial migration: regulation at the apical epithelial surface by Fc-mediated events. Am. J. Physiol. 280: G746-G754.
35. Colgan, S. P., C. A. Parkos, C. Delp, M. A. Arnaout, and J. L. Madara. 1993. Neutrophil migration across cultured intestinal epithelial monolayers is modulated by epithelial exposure to IFN-γ in a highly polarized fashion. J. Cell Biol. 120: 785-798.
36. Lopez-Cabrera, M., A. Nueda, A. Vara, J. Garcia-Aguilar, A. Tugores, and A. L. Corbi. 1993. Characterization of the p150, 95 leukocyte integrin α subunit (CD11c) gene promoter: identification of cis-acting elements. J. Biol. Chem. 268: 1187-1193.
37. Zen, K., T. A. Reaves, I. Soto, and Y. Liu. 2006. Response to genistein: assaying the activation status and chemotaxis efficacy of isolated neutrophils. J. Immunol. Methods 309: 86-98.
38. Nakano, N., K. Fukuhara-Takaki, T. Jono, K. Nakajou, N. Eto, S. Horiuchi, M. Takeya, and R. Nagai. 2006. Association of advanced glycation end products with A549 cells, a human pulmonary epithelial cell line, is mediated by a receptor distinct from the scavenger receptor family and RAGE. J. Biochem. 139: 821-829.
39. Zill, H., S. Bek, T. Hofmann, J. Huber, O. Frank, M. Lindenmeier, B. Weigle, H. F. Erbersdobler, S. Scheidler, A. E. Busch, and V. Faist. 2003. RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem. Biophys. Res. Commun. 300: 311-315.
40. Bendik, I., P. Schraml, and C. U. Ludwig. 1999. Simple and fast method to test the receptor for advanced glycosylated endproducts (RAGE) for its tumor suppressive potential using the Tet-On system. J. Recept. Signal Transduct. Res. 19: 717-728.
41. Neeper, M., A. M. Schmidt, J. Brett, S. D. Yan, F. Wang, Y. C. Pan, K. Elliston, D. Stern, and A. Shaw. 1992. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267: 14998-15004.
42. Anderson, J. M., B. R. Stevenson, L. A. Jesaitis, D. A. Goodenough, and M. S. Mooseker. 1988. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J. Cell Biol. 106: 1141-1149.
43. Sunahori, K., M. Yamamura, J. Yamana, K. Takasugi, M. Kawashima, and H. Makino. 2006. Increased expression of receptor for advanced glycation end products by synovial tissue macrophages in rheumatoid arthritis. Arthritis Rheum. 54: 97-104.
44. Basta, G., G. Lazzerini, M. Massaro, T. Simoncini, P. Tanganelli, C. Fu, T. Kislinger, D. M. Stern, A. M. Schmidt, and R. De Caterina. 2002. Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: a mechanism for amplification of inflammatory responses. Circulation 105: 816-822.
45. Katz, J., R. M. Caudle, I. Bhattacharyya, C. M. Stewart, and D. M. Cohen. 2005. Receptor for advanced glycation end product (RAGE) upregulation in human gingival fibroblasts incubated with nornicotine. J. Periodontol. 76: 1171-1174.
46. Hou, F. F., H. Ren, W. F. Owen, Jr., Z. J. Guo, P. Y. Chen, A. M. Schmidt, T. Miyata, and X. Zhang. 2004. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J. Am. Soc. Nephrol. 15: 1889-1896.
47. Parkos, C. A., S. P. Colgan, A. E. Bacarra, A. Nusrat, C. Delp-Archer, S. Carlson, D. H. Su, and J. L. Madara. 1995. Intestinal epithelia (T84) possess basolateral ligands for CD11b/CD18-mediated neutrophil adherence. Am. J. Physiol. 268: C472-C479.
48. Springer, T. A. 2002. Predicted and experimental structures of integrins and β-propellers. Curr. Opin. Struct. Biol. 12: 802-813.
49. Balsam, L. B., T. W. Liang, and C. A. Parkos. 1998. Functional mapping of CD11b/CD18 epitopes important in neutrophil-epithelial interactions: a central role of the I domain. J. Immunol. 160: 5058-5065.
50. Liu, Y., A. Nusrat, F. J. Schnell, T. A. Reaves, S. Walsh, M. Pochet, and C. A. Parkos. 2000. Human junction adhesion molecule regulates tight junction resealing in epithelia. J. Cell Sci. 113(Pt. 13): 2363-2374.
51. Moser, B., B. I. Hudson, and A. M. Schmidt. 2005. Soluble RAGE: a hot new biomarker for the hot joint? Arthritis Res. Ther. 7: 142-144.
52. Wendt, T. M., N. Tanji, J. Guo, T. R. Kislinger, W. Qu, Y. Lu, L. G. Bucciarelli, L. L. Rong, B. Moser, G. S. Markowitz, et al. 2003. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am. J. Pathol. 162: 1123-1137.
53. Cecil, D. L., K. Johnson, J. Rediske, M. Lotz, A. M. Schmidt, and R. Terkeltaub. 2005. Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J. Immunol. 175: 8296-8302.
54. Steenvoorden, M. M., T. W. Huizinga, N. Verzijl, R. A. Bank, H. K. Ronday, H. A. Luning, F. P. Lafeber, R. E. Toes, and J. DeGroot. 2006. Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes. Arthritis Rheum. 54: 253-263.
55. Zhou, J., B. Cai, Y. P. Jang, S. Pachydaki, A. M. Schmidt, and J. R. Sparrow. 2005. Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp. Eye Res. 80: 567-580.
56. Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert, J. Chen, M. Hong, T. Luther, T. Henle, I. Kloting, et al. 2001. Diabetes-associated sustained activation of the transcription factor nuclear factor-κB. Diabetes 50: 2792-2808.
57. Lohwasser, C., D. Neureiter, B. Weigle, T. Kirchner, and D. Schuppan. 2006. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-α. J. Invest. Dermatol. 126: 291-299.
58. Diamond, M. S., D. E. Staunton, A. R. de Fougerolles, S. A. Stacker, J. Garcia-Aguilar, M. L. Hibbs, and T. A. Springer. 1990. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 111: 3129-3139.
59. Altieri, D. C., R. Bader, P. M. Mannucci, and T. S. Edgington. 1988. Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen. J. Cell Biol. 107: 1893-1900.
60. Altieri, D. C., and T. S. Edgington. 1988. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J. Biol. Chem. 263: 7007-7015.
61. Cai, T. Q., and S. D. Wright. 1996. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, αMβ2) and modulates polymorphonuclear leukocyte adhesion. J. Exp. Med. 184: 1213-1223.
62. Yang, L., R. M. Froio, T. E. Sciuto, A. M. Dvorak, R. Alon, and F. W. Luscinskas. 2005. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow. Blood 106: 584-592.
63. Edens, H. A., B. P. Levi, D. L. Jaye, S. Walsh, T. A. Reaves, J. R. Turner, A. Nusrat, and C. A. Parkos. 2002. Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J. Immunol. 169: 476-486.
64. Sorci, G., F. Riuzzi, A. L. Agneletti, C. Marchetti, and R. Donato. 2004. S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner. J Cell. Physiol. 199: 274-283.
65. Nitti, M., C. d'Abramo, N. Traverso, D. Verzola, G. Garibotto, A. Poggi, P. Odetti, D. Cottalasso, U. M. Marinari, M. A. Pronzato, and C. Domenicotti. 2005. Central role of PKCδ in glycoxidation-dependent apoptosis of human neurons. Free Radical Biol. Med. 38: 846-856.